FibroBiologics (FBLG) announced the filing of a patent application with the United States Patent and Trademark Office covering methods employing fibroblasts or other Tissue Factor-expressing cells to ...
HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the ...
In a newly published review, Professor Xiao-Jun Huang's team at Peking University People's Hospital explore how haploidentical hematopoietic stem cell transplantation (haplo-HSCT), once limited by ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Every year, tens of thousands of people in the U.S. undergo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback